34784444|t|mTOR-mediated autophagy in the hippocampus is involved in perioperative neurocognitive disorders in diabetic rats.
34784444|a|INTRODUCTION: Perioperative neurocognitive disorders (PND) are common neurological complications after surgery. Diabetes mellitus (DM) has been reported to be an independent risk factor for PND, but little is known about its mechanism of action. Mammalian target of rapamycin (mTOR) signaling is crucial for neuronal growth, development, apoptosis, and autophagy, but the dysregulation of mTOR signaling leads to neurological disorders. The present study investigated whether rapamycin can attenuate PND by inhibiting mTOR and activating autophagy in diabetic rats. METHODS: Male diabetic Sprague-Dawley rats underwent tibial fracture surgery under isoflurane anesthesia to establish a PND model. Cognitive functions were examined using the Morris water maze test. The levels of phosphorylated mTOR (p-mTOR), phosphorylated tau (p-tau), autophagy-related proteins (Beclin-1, LC3), and apoptosis-related proteins (Bax, Bcl-2, cleaved caspase-3) in the hippocampus were examined on postoperative days 3, 7, and 14 by Western blot. Hippocampal amyloid beta (Abeta) levels were examined by immunohistochemistry. RESULTS: The data showed that surgical trauma and/or DM impaired cognitive function, induced mTOR activation, and decreased Beclin-1 levels and the LC3-II/I ratio. The levels of Abeta and p-tau and the hippocampal apoptotic responses were significantly higher in diabetic or surgery-treated rats than in control rats and were further increased in diabetic rats subjected to surgery. Pretreatment of rats with rapamycin inhibited mTOR hyperactivation and restored autophagic function, effectively decreasing tau hyperphosphorylation, Abeta deposition, and apoptosis in the hippocampus. Furthermore, surgical trauma-induced neurocognitive disorders were also reversed by pretreatment of diabetic rats with rapamycin. CONCLUSION: The results demonstrate that mTOR hyperactivation regulates autophagy, playing a critical role in the mechanism underlying PND, and reveal that the modulation of mTOR signaling could be a promising therapeutic strategy for PND in patients with diabetes.
34784444	0	4	mTOR	Gene	56718
34784444	72	96	neurocognitive disorders	Disease	MESH:D019965
34784444	100	108	diabetic	Disease	MESH:D003920
34784444	109	113	rats	Species	10116
34784444	143	167	neurocognitive disorders	Disease	MESH:D019965
34784444	169	172	PND	Disease	MESH:D019965
34784444	185	211	neurological complications	Disease	MESH:D002493
34784444	227	244	Diabetes mellitus	Disease	MESH:D003920
34784444	246	248	DM	Disease	MESH:D003920
34784444	305	308	PND	Disease	MESH:D019965
34784444	361	390	Mammalian target of rapamycin	Gene	56718
34784444	392	396	mTOR	Gene	56718
34784444	504	508	mTOR	Gene	56718
34784444	528	550	neurological disorders	Disease	MESH:D009461
34784444	591	600	rapamycin	Chemical	MESH:D020123
34784444	615	618	PND	Disease	MESH:D019965
34784444	633	637	mTOR	Gene	56718
34784444	666	674	diabetic	Disease	MESH:D003920
34784444	675	679	rats	Species	10116
34784444	695	703	diabetic	Disease	MESH:D003920
34784444	719	723	rats	Species	10116
34784444	734	749	tibial fracture	Disease	MESH:D013978
34784444	764	774	isoflurane	Chemical	MESH:D007530
34784444	801	804	PND	Disease	MESH:D019965
34784444	909	913	mTOR	Gene	56718
34784444	917	921	mTOR	Gene	56718
34784444	980	988	Beclin-1	Gene	114558
34784444	990	993	LC3	Gene	25291
34784444	1028	1031	Bax	Gene	24887
34784444	1033	1038	Bcl-2	Gene	24224
34784444	1048	1057	caspase-3	Gene	25402
34784444	1170	1175	Abeta	Gene	54226
34784444	1262	1268	trauma	Disease	MESH:D014947
34784444	1276	1278	DM	Disease	MESH:D003920
34784444	1279	1306	impaired cognitive function	Disease	MESH:D003072
34784444	1316	1320	mTOR	Gene	56718
34784444	1347	1355	Beclin-1	Gene	114558
34784444	1371	1374	LC3	Gene	25291
34784444	1401	1406	Abeta	Gene	54226
34784444	1486	1494	diabetic	Disease	MESH:D003920
34784444	1514	1518	rats	Species	10116
34784444	1535	1539	rats	Species	10116
34784444	1570	1578	diabetic	Disease	MESH:D003920
34784444	1579	1583	rats	Species	10116
34784444	1622	1626	rats	Species	10116
34784444	1632	1641	rapamycin	Chemical	MESH:D020123
34784444	1652	1656	mTOR	Gene	56718
34784444	1756	1761	Abeta	Gene	54226
34784444	1830	1836	trauma	Disease	MESH:D014947
34784444	1845	1869	neurocognitive disorders	Disease	MESH:D019965
34784444	1908	1916	diabetic	Disease	MESH:D003920
34784444	1917	1921	rats	Species	10116
34784444	1927	1936	rapamycin	Chemical	MESH:D020123
34784444	1979	1983	mTOR	Gene	56718
34784444	2073	2076	PND	Disease	MESH:D019965
34784444	2112	2116	mTOR	Gene	56718
34784444	2173	2176	PND	Disease	MESH:D019965
34784444	2180	2188	patients	Species	9606
34784444	2194	2202	diabetes	Disease	MESH:D003920
34784444	Negative_Correlation	MESH:D020123	56718
34784444	Association	MESH:D019965	56718
34784444	Negative_Correlation	MESH:D020123	MESH:D003920
34784444	Negative_Correlation	MESH:D020123	MESH:D019965
34784444	Positive_Correlation	MESH:D003920	56718
34784444	Association	MESH:D014947	25291
34784444	Positive_Correlation	MESH:D014947	56718
34784444	Positive_Correlation	MESH:D003920	54226
34784444	Negative_Correlation	MESH:D007530	MESH:D013978
34784444	Negative_Correlation	MESH:D003920	114558
34784444	Positive_Correlation	114558	56718
34784444	Association	MESH:D003072	56718
34784444	Negative_Correlation	MESH:D003920	25291
34784444	Negative_Correlation	MESH:D020123	MESH:D014947
34784444	Negative_Correlation	MESH:D020123	54226
34784444	Association	54226	56718
34784444	Negative_Correlation	MESH:D014947	114558
34784444	Association	MESH:D009461	56718

